Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10BB12	DIAMERIL	G	Glimepiride - 3mg	3mg	Tablet	261,089 L.L
C01CA04	DOPAMINE RENAUDIN	G	Dopamine HCl - 200mg/5ml	4%	Injectable concentrated solution	1,107,326 L.L
N05CM18	DEXMEDETOMIDINE EVER PHARMA	G	Dexmedetomidine HCl - 400mcg/4ml	400mcg/4ml	Injectable concentrate for solution	15,543,897 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 400mg	400mg	Injectable lyophilised powder for solution+diluent	450,187 L.L
M01AE01	DOLORAZ 400	G	Ibuprofen - 400mg	400mg	Capsule	295,645 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 400mg/20ml	400mg/20ml	Injectable concentrate for solution	L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 400mg/20ml	400mg/20ml	Injectable concentrate for solution	171,503,274 L.L
C03CA01	DIURESAL	G	Furosemide - 40mg	40mg	Tablet, scored	118,258 L.L
N06AB05	DEPROX	G	Paroxetine (HCl) - 40mg	40mg	Tablet	2,909,099 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 40mg/ml	40mg/ml	Injectable suspension	182,763 L.L
A10BB12	DIAMERIL	G	Glimepiride - 4mg	4mg	Tablet	322,522 L.L
N05AX08	DEPIA	G	Risperidone - 4mg	4mg	Tablet, scored	499,142 L.L
H02AB02	DEXAMETHASONE MEDIS	G	Dexamethasone Phosphate - 4mg/1ml	4mg/1ml	Injectable solution	1,154,361 L.L
M05BA08	DROMEZON	G	Zoledronic acid - 4mg/5ml	4mg/5ml	Injectable concentrate for solution	4,577,128 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
D04AX01	DOXIDERM	G	Doxepin (HCl) - 5%	5%	Cream	1,037,958 L.L
A11CC05	D-VITAL	G	Vitamin D3 - 50,000IU	50,000IU	Capsule, hard	712,620 L.L
A11CC05	DIBASE	G	Vitamin D3 - 50000IU/2.5ml	50,000IU/2.5ml	Solution	755,239 L.L
A11CC05	D-ESTER	G	Vitamin D3 - 50000IU	50000IU	Capsule	1,187,701 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 500mg	500mg	Tablet, enteric coated	479,752 L.L
N03AG01	DEPAKINE CHRONO	B	Valproic acid - 145mg, Sodium Valproate - 333mg	500mg	Tablet, coated, scored, prolonged release	362,837 L.L
V03AC03	DEFIROX	G	Deferasirox - 500mg	500mg	Tablet, dispersible	38,502,953 L.L
V03AC03	DIFIRAX	G	Deferasirox - 500mg	500mg	Tablet, dispersible	38,637,010 L.L
B02BX01	DICYNONE	B	Etamsylate - 500mg	500mg	Capsule	1,311,590 L.L
C05BX01	DOXIUM	B	Calcium dobesilate - 500mg	500mg	Capsule	2,151,492 L.L
C05BX01	DOXIUM	B	Calcium dobesilate - 500mg	500mg	Capsule	1,323,685 L.L

...